1 Introduction to Research & Analysis Reports
1.1 CAR T-cell Therapy Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR T-cell Therapy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR T-cell Therapy Drug Overall Market Size
2.1 Global CAR T-cell Therapy Drug Market Size: 2022 VS 2029
2.2 Global CAR T-cell Therapy Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR T-cell Therapy Drug Players in Global Market
3.2 Top Global CAR T-cell Therapy Drug Companies Ranked by Revenue
3.3 Global CAR T-cell Therapy Drug Revenue by Companies
3.4 Top 3 and Top 5 CAR T-cell Therapy Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies CAR T-cell Therapy Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR T-cell Therapy Drug Players in Global Market
3.6.1 List of Global Tier 1 CAR T-cell Therapy Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR T-cell Therapy Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global CAR T-cell Therapy Drug Market Size Markets, 2022 & 2029
4.1.2 CD19-targeted
4.1.3 BCMA-targeted
4.2 By Type – Global CAR T-cell Therapy Drug Revenue & Forecasts
4.2.1 By Type – Global CAR T-cell Therapy Drug Revenue, 2018-2023
4.2.2 By Type – Global CAR T-cell Therapy Drug Revenue, 2024-2029
4.2.3 By Type – Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global CAR T-cell Therapy Drug Market Size, 2022 & 2029
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 By Application – Global CAR T-cell Therapy Drug Revenue & Forecasts
5.2.1 By Application – Global CAR T-cell Therapy Drug Revenue, 2018-2023
5.2.2 By Application – Global CAR T-cell Therapy Drug Revenue, 2024-2029
5.2.3 By Application – Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global CAR T-cell Therapy Drug Market Size, 2022 & 2029
6.2 By Region – Global CAR T-cell Therapy Drug Revenue & Forecasts
6.2.1 By Region – Global CAR T-cell Therapy Drug Revenue, 2018-2023
6.2.2 By Region – Global CAR T-cell Therapy Drug Revenue, 2024-2029
6.2.3 By Region – Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America CAR T-cell Therapy Drug Revenue, 2018-2029
6.3.2 US CAR T-cell Therapy Drug Market Size, 2018-2029
6.3.3 Canada CAR T-cell Therapy Drug Market Size, 2018-2029
6.3.4 Mexico CAR T-cell Therapy Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe CAR T-cell Therapy Drug Revenue, 2018-2029
6.4.2 Germany CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.3 France CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.4 U.K. CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.5 Italy CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.6 Russia CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.7 Nordic Countries CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.8 Benelux CAR T-cell Therapy Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia CAR T-cell Therapy Drug Revenue, 2018-2029
6.5.2 China CAR T-cell Therapy Drug Market Size, 2018-2029
6.5.3 Japan CAR T-cell Therapy Drug Market Size, 2018-2029
6.5.4 South Korea CAR T-cell Therapy Drug Market Size, 2018-2029
6.5.5 Southeast Asia CAR T-cell Therapy Drug Market Size, 2018-2029
6.5.6 India CAR T-cell Therapy Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America CAR T-cell Therapy Drug Revenue, 2018-2029
6.6.2 Brazil CAR T-cell Therapy Drug Market Size, 2018-2029
6.6.3 Argentina CAR T-cell Therapy Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa CAR T-cell Therapy Drug Revenue, 2018-2029
6.7.2 Turkey CAR T-cell Therapy Drug Market Size, 2018-2029
6.7.3 Israel CAR T-cell Therapy Drug Market Size, 2018-2029
6.7.4 Saudi Arabia CAR T-cell Therapy Drug Market Size, 2018-2029
6.7.5 UAE CAR T-cell Therapy Drug Market Size, 2018-2029
7 CAR T-cell Therapy Drug Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis CAR T-cell Therapy Drug Major Product Offerings
7.1.4 Novartis CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences CAR T-cell Therapy Drug Major Product Offerings
7.2.4 Gilead Sciences CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Major Product Offerings
7.3.4 Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 J & J
7.4.1 J & J Company Summary
7.4.2 J & J Business Overview
7.4.3 J & J CAR T-cell Therapy Drug Major Product Offerings
7.4.4 J & J CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.4.5 J & J Key News & Latest Developments
7.5 JW Therapeutics
7.5.1 JW Therapeutics Company Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics CAR T-cell Therapy Drug Major Product Offerings
7.5.4 JW Therapeutics CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.5.5 JW Therapeutics Key News & Latest Developments
7.6 FOSUNKite
7.6.1 FOSUNKite Company Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite CAR T-cell Therapy Drug Major Product Offerings
7.6.4 FOSUNKite CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.6.5 FOSUNKite Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. CAR T-cell Therapy Drug Market Opportunities & Trends in Global Market
Table 2. CAR T-cell Therapy Drug Market Drivers in Global Market
Table 3. CAR T-cell Therapy Drug Market Restraints in Global Market
Table 4. Key Players of CAR T-cell Therapy Drug in Global Market
Table 5. Top CAR T-cell Therapy Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CAR T-cell Therapy Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CAR T-cell Therapy Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies CAR T-cell Therapy Drug Product Type
Table 9. List of Global Tier 1 CAR T-cell Therapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR T-cell Therapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - CAR T-cell Therapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CAR T-cell Therapy Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - CAR T-cell Therapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CAR T-cell Therapy Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global CAR T-cell Therapy Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CAR T-cell Therapy Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis CAR T-cell Therapy Drug Product Offerings
Table 32. Novartis CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences CAR T-cell Therapy Drug Product Offerings
Table 36. Gilead Sciences CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb CAR T-cell Therapy Drug Product Offerings
Table 40. Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. J & J Company Summary
Table 43. J & J CAR T-cell Therapy Drug Product Offerings
Table 44. J & J CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 45. J & J Key News & Latest Developments
Table 46. JW Therapeutics Company Summary
Table 47. JW Therapeutics CAR T-cell Therapy Drug Product Offerings
Table 48. JW Therapeutics CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 49. JW Therapeutics Key News & Latest Developments
Table 50. FOSUNKite Company Summary
Table 51. FOSUNKite CAR T-cell Therapy Drug Product Offerings
Table 52. FOSUNKite CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 53. FOSUNKite Key News & Latest Developments
List of Figures
Figure 1. CAR T-cell Therapy Drug Segment by Type in 2022
Figure 2. CAR T-cell Therapy Drug Segment by Application in 2022
Figure 3. Global CAR T-cell Therapy Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CAR T-cell Therapy Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global CAR T-cell Therapy Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR T-cell Therapy Drug Revenue in 2022
Figure 8. By Type - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 16. US CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 20. Germany CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 28. China CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 34. Brazil CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 37. Turkey CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gilead Sciences CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. J & J CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. JW Therapeutics CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. FOSUNKite CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
| ※参考情報 CAR-T細胞治療薬は、癌治療の新たなアプローチの一つとして注目されています。この治療法は、自らの免疫細胞を利用して癌細胞を攻撃するものです。CARは「Chimeric Antigen Receptor」の略で、日本語では「キメラ抗原受容体」と訳されます。この治療法の特徴や種類、用途、関連技術について詳しく見ていきましょう。 まず、CAR-T細胞治療の基本的な概念を理解することが重要です。身体の免疫系には、腫瘍細胞を攻撃する能力を持ったT細胞という細胞があります。しかし、癌細胞は様々な手段でこのT細胞の働きを抑制することができます。CAR-T細胞治療では、まず患者からT細胞を採取します。次に、これらのT細胞に遺伝子操作を施し、特定の癌細胞を認識して攻撃する能力を持つキメラ抗原受容体を導入します。これにより、T細胞は癌細胞を特異的に標的にすることが可能となります。改変されたT細胞は体内に戻され、癌細胞を攻撃します。 CAR-T細胞治療の大きな特徴は、その高い特異性と効果性です。通常の化学療法や放射線療法では、癌細胞だけでなく正常な細胞にも影響を与えることが多いです。そのため、副作用が大きくなることがあります。一方で、CAR-T細胞治療は、特定の抗原を持つ癌細胞に対して強力な攻撃を行うため、比較的副作用が少ないとされています。それでも、治療に伴う副作用のリスクもあり、特にサイトカイン放出症候群（CRS）や神経学的な副作用が報告されています。 CAR-T細胞治療の種類には、主に二つの大きなカテゴリーがあります。一つは、CD19をターゲットにしたCAR-T細胞治療です。CD19は多くの血液腫瘍、特に急性リンパ性白血病（ALL）や一部の非霍奇キリンパ腫（NHL）で発現しています。CD19をターゲットにしたCAR-T細胞は、高い治療効果を示すことが多く、現在多くの患者に使用されています。もう一つは、他の抗原をターゲットとするCAR-T細胞治療です。例えば、BCMA（B細胞成熟抗原）をターゲットにする治療は、マルクルノ細胞腫の患者に対して期待されています。 用途としては、主に血液癌と呼ばれる癌において顕著な効果が報告されています。特に急性リンパ性白血病や多発性骨髄腫に対して、CAR-T細胞治療は治療法としての地位を確立しつつあります。加えて、固形腫瘍に対するCAR-T細胞治療の研究も進められていますが、固形腫瘍は免疫抑制の特徴を持っているため、治療効果を上げるには多くの課題が残されています。 関連技術としては、遺伝子編集技術や、細胞培養技術、さらにはバイオマーカーの発見が挙げられます。特にCRISPR-Cas9のような遺伝子編集技術は、CAR-T細胞の設計や改良に革命をもたらす可能性があります。また、高度な細胞培養技術により、より多くのT細胞を効率的に得ることができ、治療の普及が促進されるでしょう。さらに、バイオマーカーの発見は、患者に最適な治療法を選択するための手助けになります。 今後の展望としては、CAR-T細胞治療はますます進化し、他の癌タイプに対する応用が見込まれています。また、治療法の改善や、副作用を軽減するための新たな技術やアプローチが模索されています。例えば、CAR-T細胞を「オン・オフ」できる仕組みを導入することで、副作用を制御しつつ効果を最大限に引き出す研究も進んでいます。 このように、CAR-T細胞治療薬は、癌治療の新たな選択肢として急速に発展しており、多くの患者に希望を提供しています。定期的な研究や臨床試験を通じて、さらなる効果や適応範囲の拡大が期待されており、今後の進展に注目が集まります。癌治療における新しいフロンティアとしてのCAR-T細胞治療薬の位置づけは、今後ますます重要になってくるでしょう。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
